A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer

Clinical trial NCT00992745 · COMPLETED

Trial details

NCT number: NCT00992745
Sponsor: Molecular Insight Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2009-10-01
Primary completion: 2011-09-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.